AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 55 filers reported holding AKERO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,809,155 | +108231.1% | 1,676,733 | 0.0% | 4.52% | +24.3% |
| Q2 2023 | $78,287 | +146.1% | 1,676,733 | +101.7% | 3.63% | +132.3% |
| Q1 2023 | $31,813 | -99.9% | 831,495 | 0.0% | 1.56% | -34.9% |
| Q4 2022 | $45,565,926 | +60.9% | 831,495 | 0.0% | 2.40% | +50.9% |
| Q3 2022 | $28,312,000 | +260.3% | 831,495 | 0.0% | 1.59% | +219.7% |
| Q2 2022 | $7,858,000 | -33.4% | 831,495 | 0.0% | 0.50% | -17.8% |
| Q1 2022 | $11,799,000 | -32.9% | 831,495 | 0.0% | 0.61% | -11.3% |
| Q4 2021 | $17,586,000 | -5.4% | 831,495 | 0.0% | 0.68% | +5.2% |
| Q3 2021 | $18,584,000 | -9.9% | 831,495 | 0.0% | 0.65% | -10.9% |
| Q2 2021 | $20,629,000 | -14.5% | 831,495 | 0.0% | 0.73% | -11.0% |
| Q1 2021 | $24,122,000 | +12.4% | 831,495 | 0.0% | 0.82% | +18.6% |
| Q4 2020 | $21,453,000 | -16.2% | 831,495 | 0.0% | 0.69% | -22.0% |
| Q3 2020 | $25,602,000 | +146.7% | 831,495 | +99.6% | 0.88% | +94.1% |
| Q2 2020 | $10,379,000 | +17.5% | 416,495 | 0.0% | 0.46% | -24.3% |
| Q1 2020 | $8,830,000 | -17.5% | 416,495 | -13.7% | 0.60% | -0.7% |
| Q4 2019 | $10,709,000 | -2.4% | 482,495 | 0.0% | 0.61% | -23.9% |
| Q3 2019 | $10,977,000 | +44.5% | 482,495 | +21.6% | 0.80% | +21.9% |
| Q2 2019 | $7,597,000 | – | 396,695 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |